Retinoblastoma is the most common intraocular cancer worldwide. There is some evidence to suggest that major differences exist in treatment outcomes for children with retinoblastoma from different regions, but these differences have not been assessed on a global scale. We aimed to report 3-year outcomes for children with retinoblastoma globally and to investigate factors associated with survival.
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries
Chen W.;Das P.;De Francesco S.;Du Y.;Gonzalez E.;Ji X.;Li K.;Midena E.;Ng Y.;Parrozzani R.;Peric S.;Qian J.;Said A. M.;Sultana S.;Sun X.;Suzuki S.;Tang J.;Valente P.;Vaughan L. O.;
2022
Abstract
Retinoblastoma is the most common intraocular cancer worldwide. There is some evidence to suggest that major differences exist in treatment outcomes for children with retinoblastoma from different regions, but these differences have not been assessed on a global scale. We aimed to report 3-year outcomes for children with retinoblastoma globally and to investigate factors associated with survival.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
nihms-1830257.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Creative commons
Dimensione
504.93 kB
Formato
Adobe PDF
|
504.93 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.